Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: end-stage osteoarthritis/ddh l hip major surgical or invasive procedure: l thr history of present illness: ms. is a 70 year old woman who has been having significant difficulty with her left hip for some time now. she has been involved with the physical therapy department at . she has essentially lost all of her internal rotation and significantly impacted with adls and hip function. she has had to modify her work to accommodate the amount of arthritis and its associated pain. physical therapy has had limited success. it is quite painful when she transitions from a seated position to standing. she is awoken at night with pain. she can find very little pleasure in walking since last autumn with marked increased pain in the past 6 months. it is more difficult for her to ascend and descend stairs. she does so on a non-sequential fashion and occasionally uses a cane. she elects now to undergo left total hip replacement. past medical history: pmh: htn psh: hysterectomy social history: shx: no tob, no etoh family history: n/c physical exam: her height is 5 feet 2 inches, her weight is 138 nad gait: antalgic gait, non-trendelenburg rom: virtually no internal rotation of the left hip lle is neurovascularly intact pertinent results: 10:50pm wbc-14.3*# rbc-3.85* hgb-11.6* hct-34.2* mcv-89 mch-30.2 mchc-33.9 rdw-12.2 10:50pm albumin-3.9 calcium-8.7 phosphate-4.5 magnesium-2.1 uric acid-5.1 10:50pm glucose-203* urea n-14 creat-0.9 sodium-138 potassium-4.1 chloride-101 total co2-29 anion gap-12 brief hospital course: on patient was brought to the operating room and underwent left total hip replacement. the case was uncomplicated. please see dr. operative note for details. post-operatively, the patient received iv phenergan for nausea and became unresponsive. a medical code was called and she was treated with oxygen via non-rebreather mask. within minutes she was arousable and oriented x 3. she was transferred to the icu for close monitoring and continued to improve througout the night. on the morning of pod#1 she was transferred back to the orthopaedic floor. she had no sequelae of this event. she was treated with 24 hours of antibiotic for prophylaxis of infection. lovenox was given for dvt prophylaxis and teds and pneumoboots were used. the patient was made wbat on the operative extremity with posterior hip precautions and physical therapy assisted with mobilization. home medications were restarted. prior to discharge the patient was afebrile with stable vital signs. hematocrit was stable and pain was adequately controlled on a po regimen. the operative extremity was neurovascularly intact and the wound was benign. patient was discharged in stable condition. medications on admission: : verapamil 240', hctz 25', vit c', fish oil', garlic', glucosamine', calcium + d"' discharge medications: 1. acetaminophen 325 mg tablet sig: two (2) tablet po q6h (every 6 hours). 2. enoxaparin 40 mg/0.4 ml syringe sig: one (1) syringe subcutaneous daily (daily) for 3 weeks: when course complete, start asa 325 x 3 weeks. 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 4. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 5. cholecalciferol (vitamin d3) 400 unit tablet sig: two (2) tablet po daily (daily). 6. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day). 7. ferrous sulfate 325 (65) mg tablet sig: one (1) tablet po daily (daily) for 4 weeks. 8. hexavitamin tablet sig: one (1) cap po daily (daily). 9. oxycodone 5 mg tablet sig: 0.5 - 1 tablet po q4h (every 4 hours) as needed for pain. 10. hydrochlorothiazide 25 mg tablet sig: one (1) tablet po daily (daily): hold for sbp < 100. 11. verapamil 240 mg tablet sustained release sig: one (1) tablet sustained release po q24h (every 24 hours): hold for sbp < 100. discharge disposition: home with service facility: all care vna of greater discharge diagnosis: end-stage osteoarthritis/ddh l hip discharge condition: stable. please see d/c summary - did have episode of unresponsiveness following iv phenergan administration. pt recovered completely but should not receive this medication in the future unless very closely monitored. discharge instructions: discharge instructions: seek immediate medical attention for fever >101.5, chills, increased redness, swelling or discharge from incision, chest pain, shortness of breath, or anything else that is troubling you. wound care: ok to shower but do not soak incision until follow up appointment, at least. pat incision dry after showering. staples will be removed in clinic at follow-up appointment activity: wbat lle. no strenuous exercise or heavy lifting until follow up appointment, at least. anticoagulation: take lovenox 40mg daily x 3 weeks and then take aspirin 325 mg x 3 weeks. discontinue all blood thinners 6 weeks post-operatively. other: do not drive or drink alcohol while taking narcotic pain medications. resume all home medications. call your surgeon to make follow up appointment. physical therapy: wbat lle, posterior hip dislocation precautions treatments frequency: l hip surgical incision. keep covered with dry sterile gauze dressing changed daily. leave open to air when no longer draining. followup instructions: provider: , md phone: date/time: 2:10 procedure: total hip replacement diagnoses: unspecified essential hypertension osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh other congenital deformity of hip (joint) 

Answer: The patient is high likely exposed to